Clinical Trial Update: PET Imaging Study of 68Ga-NB381 in Multiple Myeloma [EARLY_Phase 1]

View source ↗

Summary

Clinical trial update describes a PET imaging study of 68Ga-NB381 for multiple myeloma in early Phase 1, currently recruiting. Sponsor: Peking University First …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• 68Ga-NB381

Snippet

Sponsor: Peking University First Hospital | Conditions: Multiple Myeloma | EARLY_Phase 1 | Status: RECRUITING